ATF6α Activation Enhances Survival against Chemotherapy and Serves as a Prognostic Indicator in Osteosarcoma.

Neoplasia · 2019 · PMC6484364 · PMID 31029032

Europe PMC DOI

hedged sentence

0.4100

closest p · 8.2× alpha

0.4100

boldest claim

The sentences

did not reach statistical significanceP = .41not close (p > 0.1)

Using these criteria our preliminary analysis showed that patients with ATF6α(N) high tumors had a trend towards poorer histologic response when compared to the patients with ATF6α(N) low tumors (58.7 + 44.1% vs 70.7 + 35.8, respectively), however this trend did not reach statistical significance ( P = .41) ( Table 4 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.